Clinical trial
Dapsone Gel, 5% for Topical Treatment of Dermatitis Herpetiformis
NCT01115244 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dapsone Gel, 5% for Topical Treatment of Dermatitis Herpetiformis
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- July 31, 2010
- Completion date
- March 31, 2012
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.